Japan Tobacco Incorporated operates in the Cigarettes sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Japan Tobacco Incorporated with three other
companies in this sector in the United States:
Philip Morris International Incorporation
sales of $29.63 billion
of which 100%
was Cigarettes & Other),
Altria Group, Inc.
of which 114%
was Smokeable products), and
Imperial Brands PLC
of which 144%
Japan Tobacco Incorporated reported sales of $20.10 billion
December of 2018.
increase of 5.2%
versus 2017, when the company's sales were $19.11 billion.
Sales of Pharmaceutical Business saw an increase
that was more than double the company's growth rate: sales were up
10.6% in 2018, from
$935.10 million to $1.03 billion.
Japan Tobacco Incorporated also saw significant increases in sales in
Tobacco Overseas (up 7.7% to $11.90 billion)
Not all segments of Japan Tobacco Incorporated experienced an increase in sales in 2018:
sales of Other fell 7.3% to $61.81 million.
(However, this segment's sales were only a very small portion of the company's overall sales).